Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Neth Heart J ; 30(11): 526-532, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36269453

RESUMEN

INTRODUCTION: Patients with coronavirus disease 2019 (COVID-19) can present with chest pain. However, the characteristics of this chest pain are unknown. We performed a single-centre observational study to review and summarise chest pain characteristics in COVID-19 patients at first presentation to the emergency department (ED). METHODS: We collected data on characteristics of 'chest pain' reported by COVID-19 patients who attended the ED of Bernhoven Hospital, the Netherlands from 4 through 30 March 2020. RESULTS: We included 497 COVID-19 patients, of whom 83 (17%) reported chest pain upon presentation to the ED. Chest pain characteristics were: present since disease onset (88%), retrosternal location (43%), experienced as compressing/pressure pain (61%), no radiation (61%) and linked to heavy coughing (39%). Patients who reported chest pain were younger than those without chest pain (61 vs 73 years; p < 0.001). Patients with syncope were older (75 vs 72 years; p = 0.017), had a shorter duration of symptoms (5 vs 7 days; p < 0.001) and reported fewer respiratory complaints (68% vs 90%; p < 0.001) than those without syncope. Patients with new-onset atrial arrhythmias presented with a shorter duration of symptoms (5 vs 7 days; p = 0.013), experienced fewer respiratory complaints (72% vs 89%; p = 0.012) and more frequently had a history of cardiovascular disease (79% vs 50%; p = 0.003) than patients who presented without arrythmias. CONCLUSION: Chest pain and other cardiac symptoms were frequently observed in COVID-19 patients. Treating physicians should be aware that chest pain, arrhythmias and syncope can be presenting symptoms of COVID-19.

2.
BMC Med Res Methodol ; 21(1): 184, 2021 09 12.
Artículo en Inglés | MEDLINE | ID: mdl-34511068

RESUMEN

BACKGROUND: Reviews of qualitative studies allow for deeper understanding of concepts and findings beyond the single qualitative studies. Concerns on study reporting quality led to the publication of the COREQ-guidelines for qualitative studies in 2007, followed by the ENTREQ-guidelines for qualitative reviews in 2012. The aim of this meta-review is to: 1) investigate the uptake of the COREQ- and ENTREQ- checklists in qualitative reviews; and 2) compare the quality of reporting of the primary qualitative studies included within these reviews prior- and post COREQ-publication. METHODS: Reviews were searched on 02-Sept-2020 and categorized as (1) COREQ- or (2) ENTREQ-using, (3) using both, or (4) non-COREQ/ENTREQ. Proportions of usage were calculated over time. COREQ-scores of the primary studies included in these reviews were compared prior- and post COREQ-publication using T-test with Bonferroni correction. RESULTS: 1.695 qualitative reviews were included (222 COREQ, 369 ENTREQ, 62 both COREQ/ENTREQ and 1.042 non-COREQ/ENTREQ), spanning 12 years (2007-2019) demonstrating an exponential publication rate. The uptake of the ENTREQ in reviews is higher than the COREQ (respectively 28% and 17%), and increases over time. COREQ-scores could be extracted from 139 reviews (including 2.775 appraisals). Reporting quality improved following the COREQ-publication with 13 of the 32 signalling questions showing improvement; the average total score increased from 15.15 to 17.74 (p-value < 0.001). CONCLUSION: The number of qualitative reviews increased exponentially, but the uptake of the COREQ and ENTREQ was modest overall. Primary qualitative studies show a positive trend in reporting quality, which may have been facilitated by the publication of the COREQ.


Asunto(s)
Lista de Verificación , Humanos , Investigación Cualitativa
3.
Kidney Int ; 99(6): 1459-1469, 2021 06.
Artículo en Inglés | MEDLINE | ID: mdl-33340517

RESUMEN

With a rising demand for kidney transplantation, reliable pre-transplant assessment of organ quality becomes top priority. In clinical practice, physicians are regularly in doubt whether suboptimal kidney offers from older donors should be accepted. Here, we externally validate existing prediction models in a European population of older deceased donors, and subsequently developed and externally validated an adverse outcome prediction tool. Recipients of kidney grafts from deceased donors 50 years of age and older were included from the Netherlands Organ Transplant Registry (NOTR) and United States organ transplant registry from 2006-2018. The predicted adverse outcome was a composite of graft failure, death or chronic kidney disease stage 4 plus within one year after transplantation, modelled using logistic regression. Discrimination and calibration were assessed in internal, temporal and external validation. Seven existing models were validated with the same cohorts. The NOTR development cohort contained 2510 patients and 823 events. The temporal validation within NOTR had 837 patients and the external validation used 31987 patients in the United States organ transplant registry. Discrimination of our full adverse outcome model was moderate in external validation (C-statistic 0.63), though somewhat better than discrimination of the seven existing prediction models (average C-statistic 0.57). The model's calibration was highly accurate. Thus, since existing adverse outcome kidney graft survival models performed poorly in a population of older deceased donors, novel models were developed and externally validated, with maximum achievable performance in a population of older deceased kidney donors. These models could assist transplant clinicians in deciding whether to accept a kidney from an older donor.


Asunto(s)
Trasplante de Riñón , Donantes de Tejidos , Supervivencia de Injerto , Humanos , Riñón , Trasplante de Riñón/efectos adversos , Países Bajos/epidemiología , Resultado del Tratamiento , Estados Unidos/epidemiología
4.
J Clin Psychol Med Settings ; 27(1): 127-138, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31087239

RESUMEN

For immigrant chronic dialysis patients, religious behavior and religious coping may have a different impact on depressive symptoms compared to native patients. This study aims to describe both cross-sectional and longitudinal associations between religious behavior and coping with symptoms of depression for 281 native and 277 immigrant dialysis patients in the Netherlands. A higher prevalence of depressive symptoms was found in immigrant compared to native patients (49% vs. 36%). No significant cross-sectional or longitudinal associations were found in both groups between religious behavior and positive religious coping with depressive symptoms. Strong significant cross-sectional associations were found between negative religious coping items and depressive symptoms in both groups, while no longitudinal associations were found. So, similar impact of religiousness on the presence of depressive symptoms was found for both native and immigrant dialysis patients. Therefore, these results do not explain the higher prevalence of depressive symptoms found in immigrant chronic dialysis patients compared to native patients.


Asunto(s)
Trastorno Depresivo/epidemiología , Emigrantes e Inmigrantes/psicología , Religión , Diálisis Renal/psicología , Insuficiencia Renal Crónica/epidemiología , Insuficiencia Renal Crónica/psicología , Adaptación Psicológica , Anciano , Estudios de Cohortes , Comorbilidad , Estudios Transversales , Trastorno Depresivo/psicología , Emigrantes e Inmigrantes/estadística & datos numéricos , Femenino , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Países Bajos/epidemiología , Prevalencia , Diálisis Renal/estadística & datos numéricos , Insuficiencia Renal Crónica/terapia
5.
Tijdschr Psychiatr ; 55(1): 57-62, 2013.
Artículo en Holandés | MEDLINE | ID: mdl-23315697

RESUMEN

BACKGROUND: Manufacturers of energy drinks claim that their drinks can have a positive effect on cognitive performance. So far, there is little evidence that energy drinks do in fact enhance the cognitive performance of adolescents. AIM: To find out, via a series of tests, whether the manufacturers of energy drinks are justified in claiming that their drinks improve the cognitive performance of young people. METHOD: In a quasi-experimental design a number of young people (aged 15-18) were divided into three groups: a control group, each of whose members drank water beforehand; a placebo group whose members drank a glass of sugar-free lemonade, and an experimental group whose members drank a currently available energy drink (Megaforce). Pencil and paper tests were administered to the members of each group in order to measure attention and concentration, learning ability, memory, verbal and numerical reasoning, numerical aptitude and vocabulary. RESULTS: No significant differences between groups were found that could solely be ascribed to the effect of energy drink. CONCLUSION: Given the warnings about the potential health-risks of energy drinks and the fact that no evidence was found for positive effects of energy drinks on the cognitive performance of young people, we are of the opinion that youngsters should stay away from such drinks.


Asunto(s)
Cognición/efectos de los fármacos , Sacarosa en la Dieta/farmacología , Adolescente , Bebidas , Cafeína/farmacología , Femenino , Humanos , Masculino , Procesos Mentales/efectos de los fármacos , Desempeño Psicomotor/efectos de los fármacos , Análisis y Desempeño de Tareas
6.
Ned Tijdschr Geneeskd ; 149(21): 1137-41, 2005 May 21.
Artículo en Holandés | MEDLINE | ID: mdl-15940915

RESUMEN

Three boys, aged 5, 11 and 14 years, were admitted due to vomiting, fatigue and dehydration, and a 10-year-old boy was admitted due to circulatory and respiratory insufficiency. Two had Addison's disease, one had a late presentation of congenital adrenal hypoplasia due to a DAX-1 mutation and in one adrenal insufficiency was the first manifestation ofadrenoleukodystrophia. The boys recovered after treatment. It is important to recognise the symptoms of adrenal insufficiency, because treatment can be life-saving. After the initial diagnosis the underlying pathology should be sought.


Asunto(s)
Insuficiencia Suprarrenal/diagnóstico , Enfermedad de Addison/diagnóstico , Enfermedad de Addison/tratamiento farmacológico , Enfermedad de Addison/patología , Adolescente , Insuficiencia Suprarrenal/tratamiento farmacológico , Insuficiencia Suprarrenal/genética , Insuficiencia Suprarrenal/patología , Adrenoleucodistrofia/complicaciones , Adrenoleucodistrofia/diagnóstico , Niño , Preescolar , Cromosomas Humanos X , Receptor Nuclear Huérfano DAX-1 , Proteínas de Unión al ADN/genética , Humanos , Masculino , Mutación , Receptores de Ácido Retinoico/genética , Proteínas Represoras/genética , Resultado del Tratamiento
7.
Mol Cell Neurosci ; 29(1): 74-81, 2005 May.
Artículo en Inglés | MEDLINE | ID: mdl-15866048

RESUMEN

The tripartite motif proteins TRIM-2 and TRIM-3 have been put forward as putative organizers of neuronal outgrowth and structural plasticity. Here, we identified a molluscan orthologue of TRIM-2/3, named L-TRIM, which is up-regulated during in vitro neurite outgrowth of central neurons. In adult animals, L-Trim mRNA is ubiquitously expressed at low levels in the central nervous system and in peripheral tissues. Central nervous system expression of L-Trim mRNA is increased during postnatal brain development and during in vitro and in vivo neuronal regeneration. In vitro double-stranded RNA knock-down of L-Trim mRNA resulted in a >70% inhibition of neurite outgrowth. Together, our data establish a crucial role for L-TRIM in developmental neurite outgrowth and functional neuronal regeneration and indicate that TRIM-2/3 family members may have evolutionary conserved functions in neuronal differentiation.


Asunto(s)
Lymnaea/genética , Proteínas del Tejido Nervioso/genética , Neuronas/citología , Neuronas/fisiología , Dedos de Zinc/genética , Secuencia de Aminoácidos , Animales , Proteínas Portadoras/genética , Aumento de la Célula , Células Cultivadas , Secuencia Conservada , Evolución Molecular , Regulación del Desarrollo de la Expresión Génica , Datos de Secuencia Molecular , Regeneración Nerviosa/fisiología , Proteínas del Tejido Nervioso/química , Sistema Nervioso/citología , Sistema Nervioso/crecimiento & desarrollo , Estructura Terciaria de Proteína
8.
Vaccine ; 21(23): 3137-42, 2003 Jul 04.
Artículo en Inglés | MEDLINE | ID: mdl-12804840

RESUMEN

The correlation between the antigen content of inactivated Newcastle disease (ND) oil emulsion-vaccines and the serological response after immunisation was studied. The haemagglutinin-neuraminidase (HN) and fusion (F) proteins of Newcastle disease virus (NDV) were quantified in 33 inactivated oil-adjuvanted ND vaccines using isopropylmyristate (IPM)-extraction and antigen ELISAs. These commercial vaccines differed in NDV-vaccine strain, the method applied to inactivate the vaccine virus, the vaccine valence and the composition of the oil emulsions. Large differences, up to 100-fold, in the antigen quantities present in different vaccines were found. The NDV-HN content and the NDV-F content of the vaccines both highly correlated with the haemagglutination-inhibiting (HI) antibody titres after immunisation. These correlation's were found over a 10,000-fold range of applied antigen. The antigen content of the oil emulsion-vaccines also highly correlated with virus neutralising antibody titres. The presence of serum HI antibody titres in individual specific pathogens free (SPF)-chickens after immunisation with inactivated ND vaccines was highly indicative for clinical protection against challenge with the virulent NDV-Herts strain. Our results are the first to demonstrate that the protective serological response after immunisation highly correlates with the antigen content of oil-adjuvanted vaccines.


Asunto(s)
Anticuerpos Antivirales/biosíntesis , Hemaglutininas/biosíntesis , Neuraminidasa/biosíntesis , Enfermedad de Newcastle/inmunología , Enfermedad de Newcastle/prevención & control , Virus de la Enfermedad de Newcastle/inmunología , Enfermedades de las Aves de Corral/inmunología , Enfermedades de las Aves de Corral/prevención & control , Vacunas Virales/inmunología , Adyuvantes Inmunológicos , Animales , Anticuerpos Antivirales/análisis , Antígenos Virales/análisis , Antígenos Virales/inmunología , Pollos , Relación Dosis-Respuesta Inmunológica , Emulsiones , Ensayo de Inmunoadsorción Enzimática , Inmunización , Técnicas para Inmunoenzimas , Pruebas de Neutralización , Aceites , Proteínas Virales de Fusión/biosíntesis , Proteínas Virales de Fusión/genética
9.
Synapse ; 44(1): 1-7, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11842440

RESUMEN

Adrenalectomy enhances apoptosis in the rat dentate gyrus and concurrently decreases the field response of dentate cells to perforant path stimulation. Recent data showed that calcium current amplitude is increased 1 day prior to the appearance of apoptotic cells, pointing to calcium as a risk factor for the onset of apoptosis. We here tested if in vivo administration of nimodipine-thus presumably reducing dentate calcium influx through L type calcium channels-prevents the appearance of apoptotic cells and the change in field responses after adrenalectomy. It was found that nimodipine does not largely alter the number of animals with apoptosis nor the average number of apoptotic cells in the tip of the suprapyramidal blade of the dentate gyrus. After nimodipine treatment, field responses in the dentate gyrus of adrenalectomized rats were comparable to responses in adrenally intact rats. However, this was due to a reduction of the field response in slices from adrenally intact rats, rather than a prevention of synaptic impairment in adrenalectomized rats. The data clearly indicates that in vivo nimodipine treatment is insufficient to prevent apoptosis and synaptic impairment after adrenalectomy.


Asunto(s)
Apoptosis/fisiología , Canales de Calcio Tipo L/metabolismo , Señalización del Calcio/fisiología , Corticosterona/deficiencia , Giro Dentado/metabolismo , Neuronas/metabolismo , Vía Perforante/fisiología , Animales , Apoptosis/efectos de los fármacos , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/efectos de los fármacos , Señalización del Calcio/efectos de los fármacos , Corticosterona/sangre , Giro Dentado/citología , Giro Dentado/efectos de los fármacos , Estimulación Eléctrica , Potenciales Postsinápticos Excitadores/efectos de los fármacos , Potenciales Postsinápticos Excitadores/fisiología , Masculino , Neuronas/citología , Neuronas/efectos de los fármacos , Nimodipina/farmacología , Ratas , Ratas Wistar , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología
10.
Dev Biol (Basel) ; 111: 313-8, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12678255

RESUMEN

The potency of each batch of inactivated Newcastle disease virus (NDV) vaccine is measured in either a vaccination-serology or a vaccination-challenge experiment. We have developed an antigen quantification assay as an in vitro alternative for these currently prescribed in vivo potency assays. The in vitro assay consists of extraction of the viral antigens from the oil emulsion vaccines by isopropylmyristate, followed by quantification of the NDV HN-antigen in an ELISA. The analysis of 20 inactivated vaccines, representing the most common NDV-vaccines in Western Europe, indicated that large differences in antigen content exist between these vaccines. A comparison of the antigen content with the serological response after vaccination with 1/50 vaccine dose demonstrated that a reliable estimate of the potency can be made, based on the HN-antigen content of the vaccine. We therefore present our antigen quantification assay for NDV as a candidate in vitro potency assay. An international feasibility and validation study will be needed to prove the suitability and reliability of this candidate in vitro potency assay for inactivated NDV vaccines.


Asunto(s)
Antígenos Virales/análisis , Virus de la Enfermedad de Newcastle/inmunología , Animales , Antígenos Virales/inmunología , Pollos , Ensayo de Inmunoadsorción Enzimática , Pruebas de Inhibición de Hemaglutinación , Técnicas In Vitro , Enfermedad de Newcastle/prevención & control , Aceites , Estadística como Asunto , Vacunas de Productos Inactivados
11.
Brain Res ; 854(1-2): 230-4, 2000 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-10784127

RESUMEN

Recent studies showed that corticosterone and NMDA receptor activation suppress cell turn-over in the dentate gyrus through a common pathway, the NMDA receptor acting downstream of the corticosteroids. The present data show that in the absence of corticosteroids but not of NMDA receptor activation synaptic responses of dentate cells are reduced. The reduced synaptic responsiveness in the absence of corticosterone is therefore probably not caused by changes in cell turn-over.


Asunto(s)
Corticosterona/fisiología , Giro Dentado/fisiología , Vía Perforante/fisiología , Receptores de N-Metil-D-Aspartato/fisiología , Adrenalectomía , Animales , Maleato de Dizocilpina/farmacología , Estimulación Eléctrica , Antagonistas de Aminoácidos Excitadores/farmacología , Potenciales Postsinápticos Excitadores/fisiología , Masculino , Ratas , Ratas Wistar , Sinapsis/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA